Logos Global Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Logos Global Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,520,000	Closed	-$37M	–	61
2023 Q1	$37M	Buy	1,520,000 +20,000	+1%	+$438K	5.29%	5
2022 Q4	$32.1M	Hold	1,500,000	–	–	3.76%	8
2022 Q3	$26.9M	Buy	+1,500,000	New	+$19.7M	3.31%	13
2022 Q2	–	Sell	-1,800,000	Closed	-$30.3M	–	49
2022 Q1	$30.3M	Buy	1,800,000 +500,000	+38%	+$7.39M	3.93%	11
2021 Q4	$21.7M	Buy	+1,300,000	New	+$21.3M	2.24%	17
2021 Q3	–	Sell	-2,500,000	Closed	-$15.8M	–	72
2021 Q2	$15.8M	Buy	2,500,000 +1,300,000	+108%	+$8.39M	1.33%	24
2021 Q1	$7.42M	Buy	+1,200,000	New	+$7.28M	0.72%	26
2020 Q3	–	Sell	-900,000	Closed	-$4.59M	–	65
2020 Q2	$4.59M	Buy	+900,000	New	+$3.75M	0.92%	34
2020 Q1	–	Sell	-523,462	Closed	-$4.49M	–	55
2019 Q4	$4.49M	Buy	+523,462	New	+$1.87M	1.11%	26

Other funds holding ISEE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Logos Global Management's ISEE Position: Q2 2023 in Review

Logos Global Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2023, closing a stake of 1,520,000 shares — an estimated $37M sold.

Logos Global Management first reported a position in ISEE in Q4 2019 and held it in 9 quarters. The position peaked at $37M in Q1 2023. 256 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.

Logos Global Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Logos Global Management sold 1,520,000 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $37M.
Logos Global Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2019 and held it in 9 quarters.
Logos Global Management's IVERIC bio, Inc. Common Stock position peaked at $37M in Q1 2023.
256 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.

Based on Logos Global Management's 13F filing for Q2 2023, filed 14 Aug 2023.